Xinfu Sues Xinfa For Patent Infringement
This article was originally published in PharmAsia News
Executive Summary
Xinfu Pharm, the number one global supplier of calcium D-pantothenate with an annual output of 6,500 tons, now faces serious competition from Shandong Xinfa Pharmaceutical. The latter's output ballooned dramatically from 600 tons to 5,000 tons over the last two years. Xinfu has filed a lawsuit against Xinfa, claiming that its rival's meteoric rise stems from infringement of Xinfu's patented technology. In response, Xinfa issued a legal declaration stating that the new technique was developed by its own researchers based on Japan Daiichi's patent. Insiders reveal that the case boils down to the world's two largest calcium D-pantothenate producers slugging it out for the lucrative market. (Click here for more - Chinese language)